Table 1: Patient variables.
Caucasian |
Hispanic |
African American |
Asian |
Other |
|
|
n |
2470 |
431 |
342 |
538 |
18 |
3799 |
% |
65 |
11.3 |
9 |
14.2 |
0.5 |
|
Sex |
|
|
|
|
|
|
Female |
48% |
49% |
54% |
51% |
17% |
|
Male |
52% |
51% |
47% |
49% |
83% |
P = 0.114 |
Age Group |
|
|
|
|
|
|
< 50 |
3% |
7% |
5% |
6% |
|
|
50-59 |
12% |
15% |
14% |
15% |
22% |
|
60-69 |
29% |
28% |
36% |
28% |
33% |
|
70-79 |
32% |
32% |
30% |
26% |
17% |
|
> 80 |
26% |
18% |
16% |
25% |
28% |
P < 0.001 |
Mean Age |
71.5 |
68.5 |
68.8 |
69.5 |
69.4 |
P < 0.001 |
< 70 |
59% |
67% |
68% |
62% |
72% |
|
70 or Greater |
41% |
33% |
32% |
38% |
28% |
P = 0.006 |
Location |
|
|
|
|
|
|
Body |
15% |
13% |
14% |
17% |
11% |
|
Head |
48% |
49% |
47% |
47% |
44% |
|
Tail |
15% |
16% |
14% |
13% |
11% |
|
no |
22% |
22% |
25% |
24% |
33% |
P = 0.904 |
Tumor Size |
|
|
|
|
|
|
Mean Tumor Size (mm) |
43.7 |
44.1 |
49.3 |
47 |
35.2 |
P = 0.654 |
n |
1749 |
315 |
237 |
382 |
9 |
|
Number of Nodes Examined |
|
|
|
|
|
|
Mean Number of Nodes |
19.02 |
16.65 |
20.2 |
19.1 |
24.6 |
P = 0.330 |
n |
436 |
89 |
64 |
96 |
5 |
|
Stage |
|
|
|
|
|
|
Localized |
10% |
9% |
8% |
9% |
6% |
|
Regional Extension |
15% |
15% |
16% |
17% |
17% |
|
Nodal |
25% |
24% |
24% |
26% |
22% |
|
Distant |
53% |
53% |
52% |
52% |
44% |
|
Unknown |
5% |
3% |
6% |
6% |
6% |
P = 0.953 |
Treatment |
|
|
|
|
|
|
Surgery |
16.90% |
20.90% |
19.30% |
17.30% |
27.80% |
|
Chemotherapy |
49.90% |
55.20% |
53.80% |
53.90% |
55.60% |
|
Radiation |
8.10% |
10.20% |
8.80% |
8.20% |
11.10% |
|
Surgery + Chemo |
10.40% |
11.10% |
9.90% |
12.10% |
16.70% |
|
Surgery + Chemo + XRT |
3.10% |
4.40% |
4.70% |
2.80% |
11.10% |
|
No Treatment |
45.50% |
38.70% |
40.40% |
42.20% |
44.40% |
|
Neoadjuvant Chemo |
20.50% |
18.60% |
20.40% |
21.20% |
16.70% |
P = 0.201 |